Blood tests and better communication skills could cut over-prescribing of antibioticsMay 21, 2009Improving communications skills and the use of a simple blood test could help cut the growing number of inappropriate prescriptions of antibiotics, a joint Cardiff University trial has discovered. In a major new clinical trial, published in the British Medical Journal, a team of researchers from Cardiff University's School of Medicine together with researchers from the Maastricht University Medical Centre in the Netherlands found those GPs in primary care who underwent training in advanced communications skills and those who made use of a simple blood test prescribed fewer antibiotics for lower respiratory tract infections, which generally do not respond to antibiotics. Professor Christopher Butler, Head of Department of Primary Care and Public Health at Cardiff University who led the trial, said: "As the problem of bacteria resistant to antibiotic treatment grows, researchers from around the world are seeking ways to improve the quality of antibiotic prescribing. Prescribing antibiotics only when patients will clearly benefit, reduces the pressure that drives antibiotic resistance. "Conditions like acute bronchitis account for some 80% of all lower respiratory tract infections and despite evidence of little or no benefit from antibiotics, the majority of these patients are still prescribed antibiotics. "We know that with the many pressures facing GPs, including worry about leaving pneumonia untreated, they often give patients "the benefit of the doubt" and prescribe antibiotics. Our clinical trial therefore sought to evaluate ways antibiotic prescribing could be reduced without adversely affecting patient recovery or satisfaction with care." The trial evaluated an 'illness focussed' approach, where clinicians seek to better understand the patient's illness experience and communicate more effectively about management, and a 'disease focussed' approach, where clinicians focus on diagnosis, in this case, a simple point-of-care blood test. The trial randomised 20 general practices in the Netherlands, where 40 GPs managed 431 patients with lower respiratory tract infection. Dr Kerry Hood, Director of the South East Wales Trials Unit said, "The results showed that 54% of GPs practising according to usual care prescribed antibiotics, whereas 27% of those who had been trained in the advanced communication and 31% of the GPs who used the blood test methods did so. Only 23% of GPs who were trained in the advanced communication skills and who used the blood test prescribed antibiotics." Professor Butler added, "This international collaboration between primary care researchers from Cardiff and Maastricht has shown that both an 'illness focussed' and a 'disease focussed' approach were effective in reducing antibiotic prescribing, but the two approaches combined give the greatest benefit. We need to both communicate better and improve diagnosis to do the best for our patients and to preserve antibiotic effectiveness for our children. "Importantly, the results showed that prescribing fewer antibiotics did not mean that patients were unwell for longer. Patient's recovery and satisfaction with care were not compromised by GPs not prescribing their patient antibiotics." Cardiff University |
|||||||||||||||||||||
| Related Antibiotics Current Events and Antibiotics News Articles A Second Skin Despite advances in treatment regimens and the best efforts of nurses and doctors, about 70% of all people with severe burns die from related infections. Study reveals why certain drug combinations backfire Combination drug therapy has become a staple for treating many infections. For instance, doctors treat extensively drug resistant forms of tuberculosis with one drug that breaks down the pathogen's protective barriers and opens the door for another to deliver the deathblow. New imagining technique could lead to better antibiotics and cancer drugs A recently devised method of imaging the chemical communication and warfare between microorganisms could lead to new antibiotics, antifungal, antiviral and anti-cancer drugs, said a Texas AgriLife Research scientist. UCLA researchers reconstitute enzyme that synthesizes cholesterol drug lovastatin Researchers from the UCLA Henry Samueli School of Engineering and Applied Science have for the first time successfully reconstituted in the laboratory the enzyme responsible for producing the blockbuster cholesterol-lowering drug lovastatin. Progress made on group B streptococcus vaccine Scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have completed a Phase II clinical study that indicates a vaccine to prevent Group B Streptococcus (GBS) infection is possible. Henry Ford Hospital study: A MRSA strain linked to high death rates A strain of MRSA that causes bloodstream infections is five times more lethal than other strains and has shown to have some resistance to the potent antibiotic drug vancomycin used to treat MRSA, according to a Henry Ford Hospital study. Bacteria 'launch a shield' to resist attack Researchers from the University of Copenhagen and the Technical University of Denmark along with other collaborators in Denmark and the US found that the bacterium Pseudomonas aeruginosa can 'switch on' production of molecules that kill white blood cells - preventing the bacteria being eliminated by the body's immune system. Pumpkin skin may scare away germs The skin of that pumpkin you carve into a Jack-o'-Lantern to scare away ghosts and goblins on Halloween contains a substance that could put a scare into microbes that cause millions of cases of yeast infections in adults and infants each year. Deadly stomach infection rising in community settings, Mayo Clinic study finds Mayo Clinic researchers have found that a sometimes deadly stomach bug, Clostridium difficile is on the rise in outpatient settings. New clinical guidelines for exacerbations in cystic fibrosis The American Thoracic Society has released new clinical guidelines for the treatment of exacerbations in cystic fibrosis based on a review of the literature on current clinical practices. More Antibiotics Current Events and Antibiotics News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||